These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Access to medicines report cards. Mullard A Nat Rev Drug Discov; 2016 Nov; 15(12):811. PubMed ID: 27895336 [No Abstract] [Full Text] [Related]
4. Are rich nations up for drug reform? Check E Nature; 2006 May; 441(7090):135. PubMed ID: 16688137 [No Abstract] [Full Text] [Related]
5. Good pharma, bad pharma. Drug Ther Bull; 2013 Aug; 51(8):85. PubMed ID: 23927857 [No Abstract] [Full Text] [Related]
6. Getting new drugs to market: how individuals could do this without leaving their desks. Collier J BMJ; 2006 Dec; 333(7582):1315-7. PubMed ID: 17185722 [No Abstract] [Full Text] [Related]
7. [Drug shortage--cause and prevention]. Madsen S; Claesson U; Wesenberg GR; Endresen M; Walter AB Tidsskr Nor Laegeforen; 2012 Oct; 132(19):2154-5. PubMed ID: 23076482 [No Abstract] [Full Text] [Related]
8. Drug studies in developing countries. Olliaro PL; Vijayan R; Inbasegaran K; Lang CC; Looareesuwan S Bull World Health Organ; 2001; 79(9):894-5. PubMed ID: 11584742 [No Abstract] [Full Text] [Related]
9. An audience with... Victoria G. Hale. Hale VG Nat Rev Drug Discov; 2005 Nov; 4(11):878. PubMed ID: 16299916 [No Abstract] [Full Text] [Related]
10. More drugs, less protection. Nature; 2002 Sep; 419(6904):233. PubMed ID: 12239521 [No Abstract] [Full Text] [Related]
11. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha. 't Hoen E Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298 [No Abstract] [Full Text] [Related]
12. Pharmacy benefit managers and their obligations during serious prescription drug shortages. Teagarden JR; Epstein RS Clin Pharmacol Ther; 2013 Feb; 93(2):143-5. PubMed ID: 23337523 [TBL] [Abstract][Full Text] [Related]
13. Knight in common armor: an interview with Sir John Sulston by Jane Gitschier. Sir John Sulston PLoS Genet; 2006 Dec; 2(12):e225. PubMed ID: 17196043 [No Abstract] [Full Text] [Related]
14. Supporting the production of pharmaceuticals in Africa. Dong J; Mirza Z Bull World Health Organ; 2016 Jan; 94(1):71-2. PubMed ID: 26769999 [No Abstract] [Full Text] [Related]
15. Drug shortages in the United States: a critical evaluation of root causes and the need for action. Gupta DK; Huang SM Clin Pharmacol Ther; 2013 Feb; 93(2):133-5. PubMed ID: 23337520 [TBL] [Abstract][Full Text] [Related]
16. Drug shortage crisis affects patients and nurses. Carter D Am J Nurs; 2011 Nov; 111(11):14. PubMed ID: 22030911 [No Abstract] [Full Text] [Related]
17. Sir Michael Rawlins on being NICE--and fair--about drug development and availability. Interview by Daniel Clarke. Rawlins SM Drug Discov Today; 2005 Mar; 10(6):383-6. PubMed ID: 15808816 [No Abstract] [Full Text] [Related]
18. Out-licensing: a practical approach for improvement of access to medicines in poor countries. Friedman MA; den Besten H; Attaran A Lancet; 2003 Jan; 361(9354):341-4. PubMed ID: 12559883 [No Abstract] [Full Text] [Related]
19. Biomanufacturing, from bust to boom...to bubble? Thiel KA Nat Biotechnol; 2004 Nov; 22(11):1365-72. PubMed ID: 15529157 [No Abstract] [Full Text] [Related]